Gene signalling pathway in each experimental group
PI3K-Akt pathway genes* | P value | RAS pathway genes* | P value | PPARγ pathway genes* | P value | Adipocytokine pathway genes* | P value | AMPK pathway genes* | P value | |
TAO | 27 | 0.049 | 22 | 0.010 | 9 | 0.026 | 11 | 0.004 | 16 | 0.002 |
GPA | 41 | 0.001 | 28 | 0.005 | 13 | 0.002 | 13 | 0.004 | 26 | <0.001 |
Sarcoidosis | 105 | <0.001 | 71 | 0.001 | 22 | 0.001 | 23 | 0.048 | 44 | 0.001 |
NSOI | 50 | 0.043 | 38 | 0.006 | 16 | 0.006 | 16 | 0.009 | 26 | 0.002 |
*Number of significantly enriched genes belonging to the pathway compared with normal.
AMPK, adenosine monophosphate-activated protein kinase; GPA, granulomatosis with polyangiitis; NSOI, non-specific orbital inflammation; PPARγ, peroxisome proliferator-activated receptor-γ; TAO, thyroid-associated orbitopathy.